Effects of the Novel Multiple-Action Agent Carvedilol on Severe Nephrosclerosis in Renal Ablated Rats
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS Vol.283, No.1 283:336–344,1997
Experience of manufacturing measurement systems for biological signals
Experience of detecting Myoelctrical signals
Experience of manufacturing and sales of CE certified Human diagnostic devices
manufacturer for in vitro perfusionsystem of the wrold
manufacturer for neuropathy screening devices of Europe
Our most successful product, the Ewing Tester, offers a stand-alone solution for conducting fully automated Cardiovascular Reflex Tests. Our customers primarily work in diabetes mellitus research and treatment, with a focus on autonomic neuropathies like Cardiovascular Autonomic Neuropathy and Peripheral Autonomic Neuropathy. To better serve them, we’ve developed a device with high sensitivity and specificity for detecting peripheral neuropathic symptoms in the early stages.
For the majority of its operations, the company’s primary focus was manufacturing in-vitro pharmacological research setups. These comprehensive systems are designed for conducting isolated perfusion experiments on various tissues, including the heart, muscle stripes, vessel rings, and neural tissues, and they remain available for use.
For nearly 40 years, MDE Ltd. has been dedicated to primary preclinical research, with a particular focus on non-invasively measuring and analyzing myoelectric waves (Electrogastrogram, EGIG) across different regions of the gastrointestinal (GI) tract such as the stomach, small intestine, and large intestine, to evaluate their functionality. Throughout its evolution, MDE has partnered with numerous academic and private research groups, leading to publications of research findings in scientific journals.
Copyright © 2024 MDE GmbH All Rights Reserved
